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ERCP: a retrospective cohort study to identify predictive factors
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GRAPHICAL ABSTRACT

Background and Aims: EUS-directed transgastric ERCP (the EDGE procedure) is a simpliﬁed method of performing ERCP in Roux-en-Y gastric bypass patients. The EDGE procedure involves placement of a lumenapposing metal stent (LAMS) into the excluded stomach to serve as a conduit for passage of the duodenoscope
for pancreatobiliary intervention. Originally a multistep process, urgent indications for ERCP have led to the development of single-session EDGE (SS-EDGE) with LAMS placement and ERCP performed in the same session. The
goal of this study was to identify predictive factors of intraprocedural LAMS migration in SS-EDGE.
Methods: We conducted a multicenter retrospective review that included 9 tertiary medical centers across the United
States. Data were collected and analyzed from 128 SS-EDGE procedures. The primary outcome was intraprocedural
LAMS migration. Secondary outcomes were other procedural adverse events such as bleeding and perforation.
Results: Eleven LAMS migrations were observed in 128 procedures (8.6%). Univariate analysis of clinically relevant variables was performed, as was a binary logistic regression analysis of stent diameter and stent dilation. This
revealed that use of a smaller (15 mm) diameter LAMS was an independent predictor of intraprocedural stent
migration (odds ratio, 5.36; 95% conﬁdence interval, 1.29-22.24; P Z .021). Adverse events included 3 patients
who required surgery and 2 who experienced intraprocedural bleeding.
Conclusions: Use of a larger-diameter LAMS is a predictive factor for a nonmigrated stent and improved procedural success in SS-EDGE. Although larger patient cohorts are needed to adequately assess these ﬁndings, performance of LAMS dilation and ﬁxation may also decrease risk of intraprocedural LAMS migration and improve
procedural success. (Gastrointest Endosc 2021;94:727-32.)
(footnotes appear on last page of article)
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Roux-en-Y gastric bypass anatomy poses a unique challenge when performing ERCP because of the difﬁculty in
reaching the duodenum through the altered anatomic
route and with accessing the ampulla.1-4 In this patient
population, the biliary tree has historically been accessed
through laparoscopic assistance with gastrotomy to the
excluded stomach (laparoscopy-assisted ERCP) or balloonassisted enteroscopy ERCP (BAE-ERCP). BAE-ERCP uses an
overtube and a balloon-assisted forward-viewing endoscope
to reach the duodenum. This procedure consists of
navigation down the “roux limb,” crossing an often acutely
angulated jejunojejunostomy, advancement through the biliopancreatic limb, and then identiﬁcation of the ampulla
without the use of a side-viewing endoscope.5 Access to
the intact papilla is a signiﬁcant obstacle using this
technique because the absence of an elevator on the
balloon-assisted endoscopes increases the difﬁculty in selective cannulation. BAE-ERCP can be a lengthy and technically challenging procedure with a success rate as low as
63%.6-8 BAE-ERCP also has high rates of adverse events,
speciﬁcally perforation, which has been reported to be
as high as 10%.9
To overcome the challenges and difﬁculties of
laparoscopy-assisted ERCP and BAE-ERCP, EUS-directed
transgastric ERCP (EDGE) was ﬁrst described by Kedia
et al.10 The EDGE procedure uses a lumen-apposing metal
stent (LAMS) to access the excluded stomach from the
gastric pouch or jejunal limb under EUS guidance. The
LAMS functions as a conduit to allow passage of a standard
duodenoscope and echoendoscope into the excluded
stomach and duodenum for pancreatobiliary interventions.
EDGE allows for more efﬁcient and successful biliary tree
access in patients with Roux-en-Y gastric bypass anatomy
when compared with alternative methods.1,7,10-13
EDGE has traditionally been performed in a multistep
process with initial placement of the LAMS followed by
ERCP weeks later to allow the ﬁstula to mature. However,
endoscopists encounter situations that warrant urgent
ERCP such as ascending cholangitis and bile leaks, and
these have led to the advent of single-session EDGE (SSEDGE).2,3,14,15 This procedure consists of placement of a
LAMS followed immediately by ERCP in the same
endoscopic session. The most serious and common
adverse event of SS-EDGE is intraprocedural migration of
the LAMS resulting in a perforated viscus, particularly at
the site of the excluded stomach where endoscopic
closure may not be possible. This adverse event is mitigated in the multistep EGDE procedure because the time
interval between procedures allows for epithelialization
of the ﬁstula and stabilization of the LAMS.10
Variations of technique are favored by different physicians that may affect outcomes for SS-EDGE. Among these
differences are LAMS diameter, postplacement LAMS dilation, securing of the LAMS with endoscopic suturing, and
route of LAMS placement (transgastric vs transjejunal).
Limited data compare these factors with regard to out-

comes and adverse events. The purpose of this study
was to identify factors predictive of SS-EDGE adverse
events, speciﬁcally intraprocedural stent migration. The
primary results of this study were presented at Digestive
Disease Week 2020.
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METHODS
This was a retrospective study approved by the Thomas
Jefferson Institutional Review Board for Human Research
on January 9, 2020 (control no. 20E.04) and complied
with Health Insurance Portability and Accountability Act
regulations. All patients older than 18 years of age who underwent SS-EDGE at 9 different medical centers between
March 2016 and October 2019 were included in the study.
SS-EDGE was deﬁned as a procedure involving EUSassisted placement of a LAMS to access the excluded stomach followed by ERCP during the same endoscopic session.
The electronic medical record was queried to obtain
pertinent clinical information such as patient demographics, indications for the procedure, and periprocedural
data. Procedural data collected included endoscope manufacturers and model, LAMS diameter (15 mm vs 20 mm),
intraprocedural stent dilation, use of stent ﬁxation, type
of ﬁxation (clip, double-pigtail plastic stent, or endoscopic
suturing), route of LAMS placement (transgastric vs transjejunal), and procedural adverse events, speciﬁcally intraprocedural stent migration, bleeding, and perforation
requiring surgery. Intraprocedural stent migration was
deﬁned as migration of the LAMS inserted for access to
the excluded stomach. All included procedures were
completed in the same endoscopic session. Patients with
incomplete data were excluded from the study. No data
from patients included in this study have been published
previously.
Baseline demographic and clinical characteristics at the
time of the procedure were reported using descriptive statistics, including the Fisher exact test and risk ratios. The associations between LAMS diameter (15 mm vs 20 mm) and
stent migration were modeled separately, and the odds ratios were adjusted for LAMS dilation. The results of the logistic regression were expressed as odds ratio with 95%
conﬁdence intervals and P values. Two-tailed P < .05 was
considered statistically signiﬁcant. Statistical analysis was
performed using SPSS (IBM, version 26; Chicago, Ill, USA).
The primary outcome was intraprocedural LAMS migration during SS-EDGE. Secondary outcomes were additional
intraprocedural adverse events and interventions required
for management of adverse events (eg, endoscopic therapy
for bleeding, salvage stent placement, endoscopic closure
of perforations, and need for surgery).

Procedural techniques
LAMS placement. The EDGE procedure is performed
in a series of sequential steps (Fig. 1). Initially, the
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Figure 1. Fluoroscopic images detailing steps of single-session EUS-directed transgastric ERCP. A, Lumen-apposing metal stent (LAMS) deployment:
distal ﬂange. B, LAMS deployment: proximal ﬂange. C, Guidewire access maintained through LAMS. D, Balloon dilation of LAMS. E, Duodenoscope
passed through LAMS (arrow). F, ERCP is performed.

excluded stomach is identiﬁed endosonographically from
the remnant gastric pouch and/or the jejunum to
determine the most ideal location for access using an
echoendoscope (GF-UCT series [Olympus, Central Valley,
Pa, USA] and EG-3870UTK [Pentax, Montvale, NJ, USA]).
Considerations include proximity to the excluded stomach,
presence of intervening blood vessels, stability of the
echoendoscope, and anticipated location of gastric puncture (body of the stomach or antrum). The excluded stomach is then accessed using an EUS needle, followed by
injection of contrast for conﬁrmation of the intraluminal
location. The stomach is distended with ﬂuid and a wire
then passed through the needle into the excluded stomach
over which the LAMS (Axios; Boston Scientiﬁc, Marlborough, Mass, USA) is advanced and deployed, thereby forming a ﬁstula from the gastric pouch or jejunum to the
excluded stomach. After LAMS placement, the echoendoscope is removed. Dilation of the LAMS and ﬁxation are
performed according to the preference of the endoscopist.
ERCP. The duodenoscope (TJF-Q180V [Olympus] and
ED34-i10T2 [Pentax]) is advanced under endoscopic and/
or ﬂuoroscopic guidance through the LAMS into the
excluded stomach and then navigated into the duodenum.
Care is taken to preclude dislodgement of the duodenoscope. ERCP is then performed with standard technique,
and on completion the duodenoscope is withdrawn. The
LAMS is not removed in this session to allow for a ﬁstula

to mature and prevent a free perforation of the excluded
stomach, which cannot readily be closed endoscopically.

www.giejournal.org

Volume 94, No. 4 : 2021 GASTROINTESTINAL ENDOSCOPY 729

RESULTS
One hundred twenty-nine patients met inclusion criteria
for this study. Two patients underwent a second SS-EDGE
procedure at a later date, yielding a total of 131 SS-EDGE
procedures. Three SS-EDGE procedures were excluded
from the study because of incomplete data availability.
Thus, 128 procedures were included in the ﬁnal analysis.
The median patient age was 58 years. Demographics and
descriptive statistics of the 128 procedures are illustrated
in Table 1. Indications for ERCP were biliary obstruction
(91 patients), bile leak (15 patients), cholangitis (13
patients), and pancreatic intervention (9 patients).
Of the 129 procedures reviewed, 11 intraprocedural
LAMS migrations were observed, yielding a migration rate
of 8.6%. The associated risk ratios of factors associated
with migration are summarized in Table 2. On univariate
analysis, use of a smaller (15 mm diameter) LAMS was
predictive of intraprocedural stent migration. Statistically
fewer intraprocedural stent migrations occurred in
patients with the 20-mm-diameter LAMS (3/85, 3.5%)
compared with the 15-mm-diameter LAMS (8/43, 18.6%)
(risk ratio, 5.271; 95% conﬁdence interval, 1.47-18.87;
P Z .007). Factors not found to signiﬁcantly inﬂuence

Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by
Elsevier on December 21, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.

Maximizing success in single-session EDGE

Shinn et al

TABLE 1. Descriptive statistics on the patient population and
procedures (128 procedures)
Migration
(n [ 11)

No migration
(n [ 117)

P
value

Women

9

88

1.000

Men

2

29

<50 y

6

24

50-59 y

2

35

60-69 y

2

36

70 y

1

22

15 mm

8

35

20 mm

3

82

Gender

Age
.089

Stent size
.007

Sutures
Yes

0

38

No

11

79

Yes

9

113

No

2

4

Gastric

9

80

Jejunal

2

37

Yes

9

111

No

2

6

.033

Dilation
.084

Location
.502

mean duration to LAMS removal was 45 days after initial
placement.
A binary logistic regression analysis of stent diameter
and dilation was performed. Stent diameter was included
as a factor given that it achieved statistical signiﬁcance on
univariate analysis. Stent dilation was also included as a factor given its clinical importance and trend toward signiﬁcance on univariate analysis (Table 3). This analysis
demonstrated that a smaller stent diameter was an
independent predictor of LAMS migration, although
dilation of the LAMS was not. The 15-mm LAMSs were
more likely to migrate than the 20-mm LAMSs (odds ratio,
5.36; 95% conﬁdence interval, 1.29-22.24; P Z .021).
Although the effect of suture ﬁxation on logistic regression
was of interest clinically, the lack of any migrated sutured
stents and the small sample size of the study did not allow
for its incorporation into the model.
Of the 11 patients who experienced LAMS migration, 3
required surgery, 3 were rescued with esophageal stent
bridging, and 2 had placement of a second LAMS. In 1 patient, the defect was closed with an over-the-scope clip,
and in 2 other procedures the stents that had migrated
were able to be replaced during the same procedure.
Bleeding occurred in 2 patients and was managed endoscopically at the time of the procedure without recurrence.
No deaths occurred in the cohort.

DISCUSSION

Electrocautery*
.141

the rate of intraprocedural stent migration were LAMS dilation (9/122 migrations in dilated LAMS vs 2/6 migrations in
nondilated LAMS, P Z .084), route of LAMS placement (9/
89 migrations in transgastric access vs 2/39 migrations in
transjejunal access, P Z .502), and the use of
electrocautery-enhanced stents (9/120 migrations in electrocautery stents vs 2/8 migrations in nonelectrocautery
stents, P Z .141).
Thirty-eight LAMSs were secured with endoscopic suturing. Of the sutured LAMSs, none experienced intraprocedural migration compared with 3 of 11 nonsutured
LAMSs. On univariate analysis, absence of stent ﬁxation
with endoscopic suturing was found to be a statistically signiﬁcant predictive factor of intraprocedural stent migration
(P Z .033). Double-pigtail stents were used to anchor the
LAMS in 11 procedures. Of the LAMSs anchored with
double-pigtails stents, 3 of 11 experienced intraprocedural
migration. On univariate analysis, anchoring with a doublepigtail stent was not found to be a statistically signiﬁcant
predictive factor of stent migration (P Z .504). The

The EDGE procedure is a novel endoscopic procedure
that allows ERCP access to the duodenum in patients
with Roux-en-Y gastric bypass anatomy. EDGE improves
success and shortens procedure duration. SS-EDGE has
been described in the literature in case reports and a single
small case series of 5 patients. This is the ﬁrst multicenter
collaborative study of SS-EDGE demonstrating that
the procedure can be performed safely when there is a
need for urgent pancreaticobiliary intervention.2,3,14,15
Intraprocedural stent migration, which can occur in both
multistep and SS-EDGE procedures, is the most concerning adverse event in SS-EDGE, and factors that affect this
outcome are of great interest. This is the ﬁrst multicenter
study to investigate factors that may impact LAMS migrations in SS-EDGE.
We found that the use of the 15-mm diameter LAMSs is
the strongest predictor of intraprocedural stent migration.
Suture ﬁxation of the LAMS was clinically signiﬁcant and
improved procedural success because none of the sutured
LAMSs experienced migration; however, this factor was not
incorporated into the multivariate analysis because of the
lack of observed adverse events in this small-sized cohort,
resulting in statistical limitation. The fact that there were
no migrations suggests that this may be a powerful method
of avoiding this adverse event, and suture ﬁxation of the
LAMS has been routinely incorporated into practice for
SS-EDGE by some practitioners. Although the performance
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TABLE 2. Univariate analysis of factors associated with 11 total migrations

Stent size 15 mm vs 20 mm
Sutures vs no sutures

Risk ratio

95% Confidence interval

P value

5.271

1.473-18.868

.007

0

.033

Dilation vs no dilation

.221

.061-.808

Gastric route vs jejunal

1.972

.447-8.708

.502

Electrocautery vs no electrocautery

.300

.077-1.163

.141

Double pigtail vs no double pigtail

3.989

1.233-12.905

.504

TABLE 3. Logistic regression (reference: no dilation and 20-mm LAMS)
P value

Odds
ratio

95% Confidence
interval

LAMS dilation

.235

.313

.046-2.125

LAMS diameter 15 mm

.021

5.355

1.289-22.241

Variable

.084

in this study. Based on these results, we suggest use of
larger-diameter 20-mm LAMSs for the EDGE procedure.
Endoscopic suturing for stent ﬁxation may also serve to
decrease LAMS migration during SS-EDGE procedures.

LAMS, Lumen-apposing metal stent.
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